Abstract:Colorectal cancer is a common digestive cancer worldwide. As a comprehensive treatment for locally advanced rectal cancer (LARC), neoadjuvant therapy (NT) has been increasingly used as the standard treatment for clinical stage II/III rectal cancer. However, few patients achieve a complete pathological response, and most patients require surgical resection and adjuvant therapy. Therefore, identifying risk factors and developing accurate models to predict the prognosis of LARC patients are of great clinical significance.To establish effective prognostic nomograms and risk score prediction models to predict overall survival (OS) and disease-free survival (DFS) for LARC treated with NT.Nomograms and risk factor score prediction models were based on patients who received NT at the Cancer Hospital from 2015 to 2017. The least absolute shrinkage and selection operator regression model were utilized to screen for prognostic risk factors, which were validated by the Cox regression method. Assessment of the performance of the two prediction models was conducted using receiver operating characteristic curves, and that of the two nomograms was conducted by calculating the concordance index (C-index) and calibration curves. The results were validated in a cohort of 65 patients from 2015 to 2017.Seven features were significantly associated with OS and were included in the OS prediction nomogram and prediction model: Vascular_tumors_bolt, cancer nodules, yN, body mass index, matchmouth distance from the edge, nerve aggression and postoperative carcinoembryonic antigen. The nomogram showed good predictive value for OS, with a C-index of 0.91 (95%CI: 0.85, 0.97) and good calibration. In the validation cohort, the C-index was 0.69 (95%CI: 0.53, 0.84). The risk factor prediction model showed good predictive value. The areas under the curve for 3- and 5-year survival were 0.811 and 0.782. The nomogram for predicting DFS included ypTNM and nerve aggression and showed good calibration and a C-index of 0.77 (95%CI: 0.69, 0.85). In the validation cohort, the C-index was 0.71 (95%CI: 0.61, 0.81). The prediction model for DFS also had good predictive value, with an AUC for 3-year survival of 0.784 and an AUC for 5-year survival of 0.754.We established accurate nomograms and prediction models for predicting OS and DFS in patients with LARC after undergoing NT.

Prognostic Nomograms for Predicting Survival and Distant Metastases in Locally Advanced Rectal Cancers.

A Prognostic Nomogram in Patients with Distant Metastasis of Pancreatic Neuroendocrine Tumors: a Population-Based Study.

A Prognostic Nomogram For Predicting Recurrence And Survival In Rectal Cancers Without Neoadjuvant Treatment.

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival among Patients with Locally Advanced Rectal Cancer.

Prognostic Nomograms for Patients with Metastatic Gastric Cancer: A Large Population-Based Cohort Study and External Validation

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Colorectal Cancer Patients: A Large Population-Based Real-World Study.

A Nomogram Based on Clinical Factors to Predict Locally Advanced Stage of Rectal Cancer

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy

Accurate nomograms with excellent clinical value for locally advanced rectal cancer

Construction and Validation of a Prognostic Nomogram for Locally Recurrent Rectal Cancer: a Population-Based Study

Constructing and Validating a Prognosis Predictive Nomogram for Cancer-Specific Survival in Rectal Cancer Patients Receiving Preoperative Radiotherapy.

Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics

Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy

Development of a Nomogram for Predicting Survival in Microsatellite Stable Patients with Resected Colorectal Cancer

Prognostic Nomogram for Rectal Cancer Patients With Tumor Deposits

Establishment and Validation of a Prognostic Nomogram for Predicting Postoperative Overall Survival in Advanced Stage III–IV Colorectal Cancer Patients

Development of predictive prognostic nomogram for NECs of rectum on population-based exploration.

Individualized Prediction of Survival Benefit from Primary Tumor Resection for Patients with Unresectable Metastatic Colorectal Cancer

Nomogram for predicting overall survival in colorectal cancer with distant metastasis

Construction of a clinical survival prognostic model for middle-aged and elderly patients with stage III rectal adenocarcinoma

Predicting the risk of distant metastasis in patients with locally advanced rectal cancer using model based on pre-treatment T2WI-based radiomic features plus postoperative pathological stage